News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
708,228 Results
Type
Article (67642)
Company Profile (171)
Press Release (640415)
Section
Business (201915)
Career Advice (3092)
Deals (35211)
Drug Delivery (102)
Drug Development (82207)
Employer Resources (186)
FDA (16105)
Job Trends (15440)
News (344711)
Policy (33115)
Tag
Academia (2934)
Africa (1033)
Alliances (50484)
Alzheimer's disease (1212)
Approvals (16040)
Arizona (156)
Artificial intelligence (94)
Asia (41645)
Australia (7345)
Bankruptcy (315)
Best Places to Work (11608)
Biotechnology (116)
Breast cancer (75)
C2C Services and Suppliers (77434)
California (1954)
Canada (977)
Cancer (625)
Career advice (2612)
Cell therapy (161)
China (164)
Clinical research (64172)
Collaboration (200)
Colorado (88)
Compensation (69)
Connecticut (89)
COVID-19 (2645)
Cystic fibrosis (82)
Data (472)
Diabetes (97)
Diagnostics (6240)
Drug pricing (86)
Earnings (74755)
Employer resources (159)
Europe (96059)
Events (106895)
Executive appointments (190)
FDA (16404)
Florida (298)
Funding (179)
Gene therapy (109)
Georgia (71)
GLP-1 (591)
Government (4717)
Healthcare (19258)
Hotbed/Location (466392)
Illinois (300)
Indiana (155)
Infectious disease (2681)
Inflammatory bowel disease (104)
Interviews (580)
IPO (15793)
Job creations (4013)
Job search strategy (2202)
Kansas (93)
Layoffs (456)
Legal (7899)
Lung cancer (129)
Manufacturing (117)
Maryland (422)
Massachusetts (1553)
Medical device (13152)
Medtech (13157)
Mergers & acquisitions (19355)
Metabolic disorders (310)
Michigan (143)
Minnesota (213)
Neuroscience (1402)
New Jersey (644)
New York (642)
NextGen Class of 2024 (6927)
Non-profit (4727)
North Carolina (669)
Northern California (877)
Obesity (191)
Ohio (111)
Opinion (217)
Patents (84)
Pennsylvania (582)
People (60465)
Phase I (19838)
Phase II (28082)
Phase III (21086)
Pipeline (136)
Postmarket research (2900)
Preclinical (8714)
Radiopharmaceuticals (243)
Rare diseases (162)
Real estate (6472)
Recruiting (72)
Regulatory (21561)
Research institute (2545)
Resumes & cover letters (478)
South America (1360)
Southern California (802)
Startups (3681)
Texas (266)
United States (9064)
Vaccines (529)
Washington State (254)
Weight loss (168)
Date
Today (150)
Last 7 days (673)
Last 30 days (2792)
Last 365 days (36715)
2024 (27152)
2023 (39701)
2022 (50398)
2021 (55496)
2020 (54507)
2019 (48347)
2018 (36712)
2017 (33842)
2016 (33827)
2015 (39485)
2014 (33142)
2013 (29635)
2012 (31144)
2011 (31052)
2010 (29918)
708,228 Results for "harvard university faculty of arts and sciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Biotech Bay
NTT Research Funds New Program with Harvard Center for Brain Science
NTT Research, Inc., a division of NTT, announced that the NTT Research Foundation, a 5013 organization, has made a gift to establish the Harvard University Center for Brain Science -NTT Fellowship Program in the new field of Physics of Intelligence.
April 11, 2024
·
6 min read
Genetown
Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, will be presenting to investors at the upcoming Sidoti Small Cap Conference and KeyBanc Life Sciences & MedTech Conference, both to be held virtually in March 2024.
March 11, 2024
·
1 min read
Genetown
Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
Harvard Bioscience, Inc. announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the Jefferies Global Healthcare Conference at the Marriott Marquis in New York City on June 5, 2024.
May 23, 2024
·
1 min read
Genetown
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Benchmark Healthcare House Call Virtual Conference on May 22nd, 2024, with a live fireside chat scheduled for 9:00-9:40 am ET.
May 16, 2024
·
1 min read
Business
Harvard Apparatus Regenerative Technology Reports First Quarter 2024 Financial Results and Recent Business Highlights
Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases, today reported first quarter 2024 financial results.
May 13, 2024
·
6 min read
Genetown
Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the 14th Annual East Coast IDEAS Conference at the Jay Conference Center – Bryant Park in New York City on June 12, 2024.
June 6, 2024
·
1 min read
Press Releases
Andelyn Biosciences Expands AAV Curator™ Platform Offering to Include MyoAAV Plasmids through a License Agreement from the Broad Institute of MIT and Harvard
August 6, 2024
·
3 min read
Rosalind Franklin University Researchers Selected as 2024 “Illinois Researchers to Know”
Rosalind Franklin University of Medicine and Science research faculty have been named among “Illinois Researchers to Know” by the Illinois Science and Technology Coalition. The annual list recognizes the groundbreaking work of scientists and ten institutions driving innovation in the state.
June 4, 2024
·
2 min read
Business
Harvard Bioscience Announces First Quarter 2024 Financial ResultsStrong gross margin performance and focus on efficiency to support ongoing investments in growth
Harvard Bioscience, Inc. announced financial results for the first quarter ended March 31, 2024.
May 7, 2024
·
10 min read
1 of 70,823
Next
